Cardiovascular diseases and hypertension continue to be leading causes of morbidity and mortality worldwide, demanding a focused and sustained medical response. In India, the growing incidence of lifestyle-related cardiac disorders underscores the need for reliable, evidence-based treatment options that address both prevention and management.

Yaselle Pharmaceuticals established the Cardiac & Hypertension Care Division – Yaselle Cardiora to advance cardiovascular wellness through innovation and clinical excellence. The name “Cardiora” is derived from “Cardio” (heart) and “Aura” (essence or protection), representing our vision to safeguard the heart’s vitality through advanced, accessible, and trusted therapies. The division reflects our enduring commitment to supporting healthcare professionals in improving cardiac outcomes and enhancing patient longevity and quality of life.